VitaNova Life Sciences VNOV
OTC VNOV
$4.05 -0.45 (-10.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

VitaNova Life Sciences (VNOV) Current Deferred Revenue (2025)

Updated

VitaNova Life Sciences' Current Deferred Revenue was $4,286 in fiscal Q2 2026 (quarter ended Oct 31, 2025), down 60.2% from the prior quarter.

Analysis

VitaNova Life Sciences (VNOV) Current Deferred Revenue (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Accenture 157.60 Bn 116.88 Bn 6.13 Bn
2 Cintas 89.52 Bn 88.60 Bn 1.55 Bn
3 Iron Mountain 32.94 Bn 32.13 Bn 1.07 Bn
4 Rollins 16.91 Bn 16.45 Bn 569.95 Mn
5 APi 16.76 Bn 13.80 Bn 703.00 Mn
6 Gartner 15.49 Bn 9.18 Bn 1.19 Bn
7 UL Solutions 14.82 Bn 13.57 Bn 417.00 Mn
8 Aramark 13.80 Bn 11.74 Bn 430.34 Mn
9 Rentokil Initial 11.52 Bn 5.03 Bn -
10 VitaNova Life Sciences 35.43 Mn 29.80 Mn 30,521.00
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2025 4,286.00
Jul 31, 2025 10,775.00
API Access

VitaNova Life Sciences Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VNOV&period=max&api_key=YOUR_API_KEY